Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation.

Background: Utilization of liver grafts from hepatitis B core antibody (anti-HBc) positive donors carries the risk of reactivation of hepatitis B virus (HBV) in recipients because of post-transplant immunosuppressive therapy.

Methods: This was a retrospective study of patients who had received liver grafts from anti-HBc positive live donors between 2006 and 2016 at our institute.

Results: Out of 22 recipients [all males, mean age 45.